Pfizer BioNTech vaccine likely to be effective against B1.1.7 strain of SARS-CoV-2
02 February 2021The Pfizer BioNTech vaccine BNT162b2 is likely to be effective against the B1.1.7 variant of SARS-CoV-2, even though its efficacy is modestly affected, say scientists...